Back to Authors

Scott, D.

Mayo Clinic

Regeneron (United States)

Citations 1

Alternative Pathway Complement Activation and Low Circulating Inhibitors Associate With Severity and Mortality in COVID-19 and Non-COVID Sepsis
Meyer, N.J., Devalaraja‐Narashimha, Kishor , Ehmann, Peter, Afolayan, Sunday, DerOhannessian, Stephanie, Spade, G., Ittner, C.A.G., Turner, A.P., Esperanza, Mika, Dunn, Thomas, Weaver, JoEllen , Biobank, P. PennMedicine, Zhu, Olivia, Scott, Daniel A. , Hamon, Sara , Wistermayer, A., Hersch, L., Burczynski, Michael E., Hamilton, Jennifer D. , Jones, T.K., Shashaty, M.G.S. , Reilly, J.P., Laudański, Krzysztof , Ko, Jina , Scott, D., Hooper, Andrea T. , Glass, David J. , Giannini, Heather M. , Morton, L., FitzGerald, Garret A , Rader, Daniel J

A103. DYSREGULATED PATHWAYS IN SEPSIS AND LUNG INJURY: SEARCHING FOR TREATABLE TRAITS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A2830-A2830

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2830 Get It